Patents by Inventor Fernando Antonio Rodriguez de Fonseca

Fernando Antonio Rodriguez de Fonseca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9050347
    Abstract: The present invention relates to the use of a compound of formula (I): or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product for the prevention and/or the treatment of a disease in which the GLP-1 receptor participates or mediates, such as eating disorders or diseases, for example, obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism and cardiovascular diseases or metabolic syndrome.
    Type: Grant
    Filed: January 25, 2011
    Date of Patent: June 9, 2015
    Assignee: VIVIABIOTECH, S.L.
    Inventors: Fernando Antonio Rodríguez De Fonseca, Miguel Romero Cuevas, Laura Orio Ortíz, Juan Manuel Decara Del Olmo, Monica Alonso Scrignoli
  • Publication number: 20140031347
    Abstract: The present invention relates to the use of a compound of formula (I): or a pharmaceutically acceptable solvate or salt thereof in the preparation of a medicinal product for the prevention and/or the treatment of a disease in which the GLP-1 receptor participates or mediates, such as eating disorders or diseases, for example, obesity, anorexia, lipid dysfunction, diabetes, hyperinsulinism and cardiovascular diseases or metabolic syndrome.
    Type: Application
    Filed: January 25, 2011
    Publication date: January 30, 2014
    Applicant: VIVIABIOTECH, S.L.
    Inventors: Fernando Antonio Rodríguez De Fonseca, Miguel Romero Cuevas, Laura Orio Ortiz, Juan Manuel Decara Del Olmo, Monica Alonso
  • Patent number: 8188312
    Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: May 29, 2012
    Assignees: Fundacion Imabis. Instituto Mediterraneo para el Avance de la Biotecnologia y la Investigacion Sanitaria, Consejo Superior de Investigaciones Cientificas
    Inventors: Fernando Antonio Rodriguez de Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, María Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos
  • Publication number: 20100179224
    Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.
    Type: Application
    Filed: January 26, 2007
    Publication date: July 15, 2010
    Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones Cientificas
    Inventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
  • Publication number: 20100048712
    Abstract: The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R1 and R2 may be the same or different, when R1 and R2 are different, R1 is a linear C12-C20 alkyl group or a linear C12-C20 alkenyl group comprising 1, 2, 3 or 4 double bonds; and R2 is a hydrogen atom or a C1-C4 alkyl group, or when R1 and R2 are the same, R1 and R2 are a linear C14-C20 alkyl group or a linear C14-C20 alkenyl group with 1, 2, 3 or 4 double bonds, and pharmaceutically acceptable salts, solvates and hydrates thereof, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulphamide derivatives are also useful for cosmetic use for reducing subcutaneous fat.
    Type: Application
    Filed: January 26, 2007
    Publication date: February 25, 2010
    Applicants: Fundacion Imabis. Instituto Mediterraneo Para El Avance De La Biotecnologia y La Investigacion Sanitaria, Consejo Superior De Investigaciones Cientificas
    Inventors: Fernando Antonio RODRIGUEZ DE FONSECA, Manuel MACIAS GONZALEZ, Javier PAVON MORON, María Pilar GOYA-LAZA, Juan Antonio PAEZ PROSPER, Carolina CANO RAMOS
  • Publication number: 20090221710
    Abstract: The present invention is related to acyclic sulfamide derivatives, useful for the manufacture of a medicament for satiety induction and ingestion control, corporal fat modulation and lipidic metabolism regulation and for the manufacture of a medicament for the treatment or prevention of diabetes and cardiovascular diseases. The acyclic sulfamide derivatives are also useful for cosmetic use.
    Type: Application
    Filed: January 26, 2007
    Publication date: September 3, 2009
    Inventors: Fernando Antonio Rodriguez De Fonseca, Manuel Macias Gonzalez, Javier Pavon Moron, Maria Pilar Goya-Laza, Juan Antonio Paez Prosper, Carolina Cano Ramos